Orthopedic technology company Conformis has agreed to be acquired by 3D-printed orthopedic company Restor3d for $2.27 per share.
Restor3d will acquire all of the outstanding stock shares of Conformis in cash, paying a 96 percent premium per share on the June 22 closing price, according to a press release.
Conformis' board of directors unanimously approved the transaction, saying that it is in the best interests of company stockholders. The transaction is expected to close at the end of the third quarter, subject to customary closing conditions.